United Kingdom · Investor

SV Health Investors

Last cheque observed Oct 2026; 70 cheques on record.

Email

Deploying nowVC firm

VentureSeries ASeries BBiotechnologyHealth Care

Deploying now
73%of best year11cheques in 12 months, 70 on record
Since the last cheque16days00hrs00min00sec
Median round$34MRounds led1 of 70Sole investor13 roundsExits1 from the portfolioMostly inUnited States, 59%
Pitch SV Health Investors

Another investor of this name exists, and we could not establish from the rounds which of them the press meant. Treat the record below as possibly belonging to either. Tell us which if you know.

SV Health Investors highlights

  1. 01

    11 cheques in the last 12 months

  2. 02

    Mostly Venture and Series A: 65% of its rounds

  3. 03

    Sole investor in 13 rounds, median $18M

  4. 04

    1 exits from the portfolio

What they do

Type
VC firm (from a list, unverified)
Cheque size
Not stated
Sectors
BiotechnologyHealth Care
Based in
United Kingdom
Cold pitches
Not stated

The record

Every round we can evidence, newest first70 appearances

  1. 2026

    10 rounds

  2. Oct
    OMass TherapeuticsSeries C · GB · Jefferson Life Sciences$310MWith 12 others
  3. Jul
    AdvanCellSeries D · AU · QRM Capital$315MWith 16 others
  4. Jul
    Alchemab TherapeuticsSeries A · GB$34MWith 4 others
  5. Jul
    Draig TherapeuticsSeries B · GB · Jefferson Life Sciences$65MWith 6 others
  6. Jun
    Harness TherapeuticsVenture · GBUndisclosedSole investor
  7. May
    NinaMEDAU · SPRIM Global Investments$14MWith 1 other
  8. May
    CerevanceSeries C · US$20MWith 1 other
  9. Mar
    Transposon TherapeuticsGrant · US$22MWith 1 other
  10. Mar
    Mestag TherapeuticsVenture · GB$40MWith 3 others
  11. Jan
    TRex BioVenture · US$50MWith 3 others
  12. 2025

    14 rounds

  13. Nov
    Imbria PharmaceuticalsVenture · USUndisclosedWith 3 others
  14. Oct
    X4 PharmaceuticalsUS$155MWith 5 others
  15. Oct
    Miach OrthopaedicsDebt · US$7.5MWith 1 other
  16. Sept
    KalVista PharmaceuticalsDebt · US$125MWith 4 others
  17. Sept
    Dualitas TherapeuticsSeries A · US$65MWith 4 others
  18. Jun
    Draig TherapeuticsSeries A · GB$140MWith 2 others
  19. May
    Therini BioSeries A · US$39MWith 4 others
  20. May
    Bardy DiagnosticsVenture · US$11MSole investor
  21. May
    Alpheus MedicalSeries B · US$52MWith 2 others
  22. Apr
    Imbria PharmaceuticalsSeries B · US$59MWith 2 others
  23. Apr
    AdvanCellGrant · AU$11MWith 1 other
  24. Mar
    PerfuzeGrowth · IE · Seroba Life Sciences$24MLed
  25. Feb
    Ria HealthSeries B · US$6.5MWith 2 others
  26. Jan
    Harness TherapeuticsVenture · GBUndisclosedSole investor
  27. 2024

    7 rounds

  28. Nov
    TRex BioSeries B · US · Avego Management$84MWith 8 others
  29. Oct
    Enara BioSeries B · GB$33MWith 2 others
  30. Oct
    Brixton BiosciencesGrant · US$2.0MWith 1 other
  31. Oct
    LOQUS23 THERAPEUTICSSeries A · GB$46MWith 2 others
  32. Sept
    CSA MedicalSeries D · US$53MSole investor
  33. Sept
    SpectrawaveSeries B · US$50MWith 2 others
  34. Apr
    CerevanceSeries B · US$47MWith 3 others
  35. 2023

    4 rounds

  36. Dec
    U.S. Renal CareVenture · US$4.0MWith 1 other
  37. Nov
    Vittoria BiotherapeuticsUS · Tellus BioVentures$15MWith 7 others
  38. Nov
    EyebiotechSeries A · US$65MWith 4 others
  39. Sept
    Sitryx TherapeuticsSeries A · GB$39MWith 4 others
  40. 2022

    2 rounds

  41. Dec
    PulmocideSeries C · GB$52MWith 3 others
  42. Mar
    Rondo TherapeuticsSeries A · US$67MWith 2 others
  43. 2021

    2 rounds

  44. Nov
    Quell TherapeuticsSeries B · GB · UCL Technology Fund$156MWith 3 others
  45. Oct
    Zerigo HealthSeries B · US$43MWith 1 other
  46. 2020

    5 rounds

  47. Nov
    Caraway TherapeuticsVentureUndisclosedWith 3 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

We hold 3 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

Exits from the portfolio

Companies it backed that were later bought or listed1 in all

Convergence PharmaceuticalsBought by Biogen Idec$675MJan 2015

An exit counts when it came after the firm's first round in the company. From historical deal records.

Who they invest alongside

The investors most often in the same rounds as SV Health Investors. A count of rooms they were both in, not a relationship either has claimed.

Eli LillyCorporate VC7rounds togetherRA Capital ManagementPrivate equity6rounds togetherBain Capital Life SciencesPrivate equity5rounds togetherJanus Henderson InvestorsPrivate equity4rounds togetherNovo HoldingsVC firm4rounds togetherSR OneCorporate VC4rounds togetherSV Life SciencesVC firm4rounds togetherAlexandria Real Estate EquitiesVC firm3rounds togetherAlexandria Venture InvestmentsVC firm3rounds togetherBritish Business BankCorporate VC3rounds togetherCanaanVC firm3rounds togetherCatalio Capital ManagementVC firm3rounds together

Recently backed

The latest companies SV Health Investors put money into.

OMass Therapeutics$310M · Oct 2026AdvanCell$315M · Jul 2026Draig Therapeutics$65M · Jul 2026Harness TherapeuticsJun 2026Cerevance$20M · May 2026Mestag Therapeutics$40M · Mar 2026

On podcasts

1 episode naming SV Health Investors in the title, and 1 more that mention it.

Mentioned in

Quick answers about SV Health Investors

What does SV Health Investors invest in?

SV Health Investors invests most often at Venture and Series A (65% of the rounds on record), in sectors such as Biotechnology and Health Care.

How active is SV Health Investors?

70 investments on record, 11 of them in the last 12 months, and it led 1. The most recent was in Oct 2026.

What has SV Health Investors invested in recently?

Its most recent investments on record: OMass Therapeutics (Series C, Oct 2026), AdvanCell (Series D, Jul 2026) and Alchemab Therapeutics (Series A, Jul 2026).

How big are SV Health Investors's cheques?

The median round it joins is $34M.

Does SV Health Investors lead rounds?

Sometimes: it led 1 of its 70 investments on record (1%).

Where does SV Health Investors invest?

Most of the companies it backs are in the United States (59%), the United Kingdom (31%) and Australia (8%).

Is SV Health Investors investing now?

Yes: it is actively investing, with 11 investments in the last 12 months.

Who does SV Health Investors invest alongside?

Most often Eli Lilly (7 rounds together), RA Capital Management (6 rounds together) and Bain Capital Life Sciences (5 rounds together).

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it